The Centers for Disease Control and Prevention — as well as the Food and Drug Administration — have published a joint letter denouncing Florida Surgeon General Joseph Ladapo.
Florida Surgeon General Joseph Ladapo and Gov. Ron DeSantis at a news conference in West Palm Beach, Florida.
They wrote,"Reports of adverse events to VAERS following vaccination do not mean that a vaccine caused the event. Since December 2020, almost 270 million people have received more than 670 million doses of COVID-19 vaccines in the U.S., with over 50 million people having received the updated bivalent vaccine."
The CDC and FDA went on to claim that studies had found a lower rate of strokes and heart attack among"Despite increased reports of these events, when the concern was examined in detail by cardiovascular experts, the risk of stroke and heart attack was actually lower in people who had been vaccinated, not higher," the letter asserted.
Timothy Nerozzi is a writer for Fox News Digital. You can follow him on Twitter @timothynerozzi and can email him at [email protected] Get the latest updates from the 2024 campaign trail, exclusive interviews and more Fox News politics content.
France Dernières Nouvelles, France Actualités
Similar News:Vous pouvez également lire des articles d'actualité similaires à celui-ci que nous avons collectés auprès d'autres sources d'information.
The FDA Approves First At-Home Flu and Covid TestThe new test aims to provide parents clarity on whether the latest sickness spreading through their house is Covid, the flu or something else entirely.
Lire la suite »
Pfizer migraine nasal spray snags FDA approval for summer launchNews of the FDA’s approval came after two randomized, double-blind, placebo-controlled studies.
Lire la suite »
FDA mammography update raises cost questionsThe FDA is updating mammography guidelines in a move that could protect people at higher risk of developing breast cancer but also drive up demand for more tests and screenings. Here's what to know about the update:
Lire la suite »
FDA approves new nasal spray to treat migraine headaches in adultsThe U.S. Food and Drug Administration approved a new nasal spray as a rapid treatment for migraine pain in adults, Pfizer said.
Lire la suite »
FDA approves new fast-acting nasal spray for migrainesThe FDA approved Pfizer's nasal spray for migraines, giving patients access to a potentially fast-acting pain relief option.
Lire la suite »
FDA to require mammogram reports include breast density information | CNNThe US Food and Drug Administration announced updates to mammography regulations on Thursday, including requiring mammography facilities to notify patients about the density of their breasts.
Lire la suite »